60 Degrees Pharmaceuticals Inc. (SXTP) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for 60 Degrees Pharmaceuticals Inc. (SXTP:NASDAQ), powered by AI.

Current Price
$1.36
Sector
Healthcare
What is the 60 Degrees Pharmaceuticals Inc. stock price forecast?

60 Degrees Pharmaceuticals Inc. is currently trading at $1.36. View real-time AI analysis on Alpha Lenz.

What is 60 Degrees Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for 60 Degrees Pharmaceuticals Inc. on Alpha Lenz.

What is 60 Degrees Pharmaceuticals Inc.'s P/E ratio?

View 60 Degrees Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.

60 Degrees Pharmaceuticals Inc.

NASDAQ · SXTP
$1.36-0.02(-1.45%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about 60 Degrees Pharmaceuticals Inc.'s future dividend policy...
Alpha Chat Insight

60 Degrees Pharmaceuticals Inc.'s ROE is -196.4%. Explore profitability and growth together.

Ask for details

Company Overview

60 Degrees Pharmaceuticals Inc. is a biotechnology company that specializes in the discovery, development, and commercialization of treatments for infectious diseases, particularly those impacting travelers and other affected populations. The company is renowned for its focused efforts on addressing tropical diseases, leveraging its expertise to offer solutions where medical needs are unmet, such as malaria prevention. With innovative approaches in pharmaceutical research and development, 60 Degrees Pharmaceuticals Inc. plays a vital role in the pharmaceutical sector, enhancing healthcare outcomes. Its contributions are significant, as it targets diseases prevalent in underserved regions, working towards creating sustainable health solutions globally. The company's focus on bringing advanced health innovations to the market positions it as a key player in addressing global health challenges, while its strategic research initiatives underline its importance in both the biotechnology landscape and global public health efforts.

CEODr. Geoffrey Stuart Dow Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees3

Company Statistics

FY 2025

Profile

N/AMarket Cap
$1.01MRevenue
0.00Shares Out
3Employees

Margins

22.26%Gross
-750.27%EBITDA
-771.64%Operating
-732.82%Pre-Tax
-732.82%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

65.15%Rev 3Yr
-14.35%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-132.46%ROA
-196.44%ROE
-132.32%ROIC

Financial Health

$1.51MCash & Cash Equivalents
$476.73KNet Debt
58.79%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

60 Degrees Pharmaceuticals Inc. (ticker: SXTP) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 3 employees.

The current price is $1.36 with a P/E ratio of -x and P/B of -x.

ROE is -196.44% and operating margin is -771.64%. Annual revenue is $1M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
60 Degrees Pharmaceuticals Inc. (SXTP) Stock Forecast 2026 $1.36 — Price, Financials & Analyst Targets | Alpha Lenz